Cited 0 times in
Suberythemic and erythemic doses of a 308-nm excimer laser treatment of stable vitiligo in combination with topical tacrolimus: A randomized controlled trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bae, JM | - |
dc.contributor.author | Kwon, SH | - |
dc.contributor.author | Ju, HJ | - |
dc.contributor.author | Kang, HY | - |
dc.date.accessioned | 2022-10-28T05:28:51Z | - |
dc.date.available | 2022-10-28T05:28:51Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 0190-9622 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/22449 | - |
dc.language.iso | en | - |
dc.subject.MESH | Administration, Topical | - |
dc.subject.MESH | Combined Modality Therapy | - |
dc.subject.MESH | Erythema | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Lasers, Excimer | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Tacrolimus | - |
dc.subject.MESH | Vitiligo | - |
dc.title | Suberythemic and erythemic doses of a 308-nm excimer laser treatment of stable vitiligo in combination with topical tacrolimus: A randomized controlled trial | - |
dc.type | Article | - |
dc.identifier.pmid | 32171812 | - |
dc.contributor.affiliatedAuthor | Kang, HY | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1016/j.jaad.2020.03.009 | - |
dc.citation.title | Journal of the American Academy of Dermatology | - |
dc.citation.volume | 83 | - |
dc.citation.number | 5 | - |
dc.citation.date | 2020 | - |
dc.citation.startPage | 1463 | - |
dc.citation.endPage | 1464 | - |
dc.identifier.bibliographicCitation | Journal of the American Academy of Dermatology, 83(5). : 1463-1464, 2020 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1097-6787 | - |
dc.relation.journalid | J001909622 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.